OPK
OPKO Health, Inc.
Diagnostics & Research · Healthcare · United States
1.66
close · 2026-10-30
value
16
cheaper than peers16
quality
28
stronger fundamentals28
ranked against
Diagnostics & Research
value
quality
31 peers
Value inputs
| measure | company | vs peers |
| price to book | 1.05× | 95 |
| price to sales | 2.11× | 82 |
| cash flow yield, 2 years ago | -3.6% | 31 |
| earnings yield, 1 year ago | -4.8% | 24 |
| earnings yield, 2 years ago | -15.1% | 21 |
| cash flow yield, 3 years ago | -9.7% | 21 |
| earnings yield, 3 years ago | -27.7% | 15 |
| cash flow yield, latest year | -15.4% | 11 |
| earnings yield, latest year | -18.1% | 11 |
| cash flow yield, 1 year ago | -16.8% | 8 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 33.6% | 64 |
| return on equity | -5.9% | 43 |
| operating margin | -15.3% | 32 |
| revenue growth | 4.3% | 18 |
4 of 4 measures available
Facts
| market cap | $1B |
| free cash flow | $54.8M |
| employees | 2,275 |
| first trade | 1995-11-02 |
| next earnings | 2026-11-04 |
| fundamentals updated | 2026-08-21 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.30 | -0.08 | -0.25 | -0.46 |
| free cash flow | -$190.8M | -$208.5M | -$44.5M | -$119.8M |
| net income | -$225.7M | -$53.2M | -$188.9M | -$328.4M |
| revenue | $606.9M | $713.1M | $863.5M | $1.00B |
| unusual items | $101.1M | $95.3M | $255,000 | $20.5M |